DK1430133T3 - En oplöselig Toll-lignende receptor - Google Patents

En oplöselig Toll-lignende receptor

Info

Publication number
DK1430133T3
DK1430133T3 DK02777127T DK02777127T DK1430133T3 DK 1430133 T3 DK1430133 T3 DK 1430133T3 DK 02777127 T DK02777127 T DK 02777127T DK 02777127 T DK02777127 T DK 02777127T DK 1430133 T3 DK1430133 T3 DK 1430133T3
Authority
DK
Denmark
Prior art keywords
polypeptide
receptor
tlr
soluble
toll
Prior art date
Application number
DK02777127T
Other languages
Danish (da)
English (en)
Inventor
Eduardo Schiffrin
Michael Affolter
Mario O Labeta
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8178601&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1430133(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestle Sa filed Critical Nestle Sa
Application granted granted Critical
Publication of DK1430133T3 publication Critical patent/DK1430133T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Paper (AREA)
DK02777127T 2001-09-17 2002-09-13 En oplöselig Toll-lignende receptor DK1430133T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01121698A EP1293566A1 (fr) 2001-09-17 2001-09-17 Un récepteur soluble de type toll
PCT/EP2002/010410 WO2003025015A2 (fr) 2001-09-17 2002-09-13 Molecule regulatrice du recepteur toll soluble

Publications (1)

Publication Number Publication Date
DK1430133T3 true DK1430133T3 (da) 2007-09-17

Family

ID=8178601

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02777127T DK1430133T3 (da) 2001-09-17 2002-09-13 En oplöselig Toll-lignende receptor

Country Status (10)

Country Link
US (1) US7230078B2 (fr)
EP (2) EP1293566A1 (fr)
JP (1) JP4354812B2 (fr)
AT (1) ATE360694T1 (fr)
AU (1) AU2002338714B2 (fr)
DE (1) DE60219808T2 (fr)
DK (1) DK1430133T3 (fr)
ES (1) ES2286292T3 (fr)
PT (1) PT1430133E (fr)
WO (1) WO2003025015A2 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6303321B1 (en) * 1999-02-11 2001-10-16 North Shore-Long Island Jewish Research Institute Methods for diagnosing sepsis
US7304034B2 (en) 2001-05-15 2007-12-04 The Feinstein Institute For Medical Research Use of HMGB fragments as anti-inflammatory agents
US7696169B2 (en) * 2003-06-06 2010-04-13 The Feinstein Institute For Medical Research Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents
CA2882022A1 (fr) * 2003-09-11 2005-03-24 Walter Newman Anticorps monoclonaux diriges contre hmgb1
JP2006096752A (ja) * 2004-08-31 2006-04-13 Ortho Corp 初乳又は初乳由来組成物、及び、初乳又は初乳由来組成物を用いた方法
WO2007011606A2 (fr) * 2005-07-18 2007-01-25 Critical Therapeutics, Inc. Hmgb1 et etats inflammatoires de la peau
WO2007076200A2 (fr) * 2005-11-28 2007-07-05 Medimmune, Inc. Antagonistes de hmgb1 et/ou rage et leurs procedes d'utilisation
EP2139916A1 (fr) * 2007-04-26 2010-01-06 Opsona Therapeutics Limited Epitope de liaison aux récepteurs apparentes à toll et compositions de liaison à celui-ci
US20100278817A1 (en) * 2007-07-05 2010-11-04 Opsona Therapeutics Ltd. Compounds and methods for the treatment of renal disease
US8734788B2 (en) 2007-08-03 2014-05-27 Opsona Therapeutics Ltd Composition and method for treatment of reperfusion injury and tissue damage
US20100326218A1 (en) * 2007-09-27 2010-12-30 Michael Boeckh Identifying a subject with an increased risk of invasive mold infection
US20100136097A1 (en) * 2008-12-02 2010-06-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Systems for modulating inflammation
US20100136095A1 (en) * 2008-12-02 2010-06-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Systems for modulating inflammation
US20100136096A1 (en) * 2008-12-02 2010-06-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Systems for modulating inflammation
US20100137247A1 (en) * 2008-12-02 2010-06-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Anti-inflammatory compositions and methods
US20100136094A1 (en) * 2008-12-02 2010-06-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Systems for modulating inflammation
US20100135983A1 (en) * 2008-12-02 2010-06-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Anti-inflammatory compositions and methods
US20100137246A1 (en) * 2008-12-02 2010-06-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Anti-inflammatory compositions and methods
GB201205633D0 (en) * 2012-03-30 2012-05-16 Opsona Therapeutics Ltd Toll-like receptor 2 binding epitope and binding members thereto

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0710477T3 (da) 1994-11-05 2001-11-05 Nestle Sa Lipidsammensætning til kosmetiske produkter
US6087116A (en) * 1997-03-12 2000-07-11 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interleukin-18 (IL-18) receptor polypeptides and their uses
ES2298905T3 (es) * 1997-10-17 2008-05-16 Genentech, Inc. Homologos de tipo toll humanos.
EP1047781B1 (fr) * 1998-01-23 2004-07-28 Immunex Corporation Recepteurs de l'interleukine-18
JP2000128900A (ja) 1998-10-26 2000-05-09 Japan Science & Technology Corp 新規トル様（Ｔｏｌｌ−ｌｉｋｅ）レセプター及びその遺伝子
WO2000075358A2 (fr) 1999-06-04 2000-12-14 Millennium Pharmaceuticals, Inc. Molecules toll et leurs utilisations

Also Published As

Publication number Publication date
JP2005511020A (ja) 2005-04-28
WO2003025015A2 (fr) 2003-03-27
US7230078B2 (en) 2007-06-12
JP4354812B2 (ja) 2009-10-28
ATE360694T1 (de) 2007-05-15
US20050124538A1 (en) 2005-06-09
WO2003025015A3 (fr) 2003-08-28
DE60219808T2 (de) 2008-01-17
AU2002338714B2 (en) 2007-06-14
EP1430133B1 (fr) 2007-04-25
EP1430133A2 (fr) 2004-06-23
PT1430133E (pt) 2007-07-27
EP1293566A1 (fr) 2003-03-19
ES2286292T3 (es) 2007-12-01
DE60219808D1 (de) 2007-06-06

Similar Documents

Publication Publication Date Title
DK1430133T3 (da) En oplöselig Toll-lignende receptor
CY1109725T1 (el) Ειδικες δεσμευομενες πρωτεϊνες και χρησεις αυτων
CY1112787T1 (el) Πολλαπλομερη του υποδοχεα κυτοκινης ζcytor17
CY1116863T1 (el) Πρωτεϊνη δεσμευσης υποδοχεα nogo
DK2314629T3 (da) Rekombinant fremstilling af blandinger af antistoffer
NO20025354D0 (no) Pattedyr-reseptorproteiner; beslektede reagenser og fremgangsmÕter
DK1129190T3 (da) Human TSLP DNA og polypeptider
CY1107339T1 (el) Mu-1, μελος της οικογενειας υποδοχεα κυτοκινης
DK2020604T3 (da) Ligand for den G-proteinkoblede receptor FPRL2
ATE443761T1 (de) Rtd receptor
ATE354657T1 (de) Basb019 proteine und gene aus moraxella catarrhalis, antigene, antikörper, und verwendungen
DK1366161T3 (da) Antagonist anti-PRO842-antistof
ATE341628T1 (de) Proteine und gene aus moraxella catarrhalis, antigene, antikörper, und verwendungen
DK1863834T3 (da) Polypeptider og nukleinsyrer, der koder disse
DK1270590T3 (da) Protein, som fremmer overlevelse af stavformede fotoreceptorceller og nucleinsyre kodende herfor
EP0890647A3 (fr) PcrA, nouveau polypeptide de la famille des hélicases d'ADN